Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 11 | 2023 | 319 | 2.560 |
Why?
|
| Suicide | 6 | 2023 | 114 | 1.570 |
Why?
|
| Analgesics, Opioid | 14 | 2022 | 239 | 1.380 |
Why?
|
| Suicide, Attempted | 10 | 2022 | 92 | 1.290 |
Why?
|
| Depression | 6 | 2022 | 479 | 1.190 |
Why?
|
| Chronic Pain | 12 | 2017 | 125 | 1.090 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 317 | 1.080 |
Why?
|
| Humans | 67 | 2023 | 16832 | 0.980 |
Why?
|
| Smoking Cessation | 4 | 2014 | 140 | 0.910 |
Why?
|
| Internet | 4 | 2014 | 207 | 0.890 |
Why?
|
| Precision Medicine | 2 | 2022 | 28 | 0.870 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 40 | 0.840 |
Why?
|
| Suicidal Ideation | 6 | 2022 | 98 | 0.750 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2020 | 63 | 0.750 |
Why?
|
| Models, Statistical | 5 | 2021 | 164 | 0.730 |
Why?
|
| Labetalol | 1 | 2022 | 9 | 0.720 |
Why?
|
| Confidentiality | 1 | 2022 | 25 | 0.720 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2022 | 34 | 0.710 |
Why?
|
| Middle Aged | 43 | 2022 | 7515 | 0.710 |
Why?
|
| Risk Assessment | 6 | 2021 | 1047 | 0.690 |
Why?
|
| Antidepressive Agents | 3 | 2021 | 140 | 0.690 |
Why?
|
| Schizophrenia | 3 | 2016 | 75 | 0.680 |
Why?
|
| Antipsychotic Agents | 3 | 2016 | 50 | 0.670 |
Why?
|
| Female | 46 | 2022 | 12193 | 0.660 |
Why?
|
| Premature Birth | 1 | 2022 | 133 | 0.650 |
Why?
|
| Male | 43 | 2022 | 9556 | 0.650 |
Why?
|
| Opioid-Related Disorders | 9 | 2017 | 174 | 0.630 |
Why?
|
| Aged | 34 | 2022 | 5901 | 0.620 |
Why?
|
| Mental Health | 5 | 2023 | 161 | 0.610 |
Why?
|
| Drug Prescriptions | 4 | 2020 | 137 | 0.600 |
Why?
|
| Adult | 34 | 2022 | 7255 | 0.600 |
Why?
|
| Outcome Assessment (Health Care) | 3 | 2017 | 199 | 0.580 |
Why?
|
| Electronic Health Records | 9 | 2021 | 702 | 0.560 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 67 | 0.520 |
Why?
|
| Self-Injurious Behavior | 3 | 2022 | 45 | 0.520 |
Why?
|
| Treatment Outcome | 11 | 2022 | 1098 | 0.500 |
Why?
|
| Longitudinal Studies | 8 | 2019 | 653 | 0.500 |
Why?
|
| Computer Simulation | 3 | 2017 | 84 | 0.500 |
Why?
|
| Propensity Score | 1 | 2017 | 78 | 0.490 |
Why?
|
| Patient Dropouts | 1 | 2016 | 16 | 0.480 |
Why?
|
| Bias | 3 | 2017 | 90 | 0.480 |
Why?
|
| Process Assessment (Health Care) | 1 | 2016 | 22 | 0.480 |
Why?
|
| Young Adult | 16 | 2020 | 2456 | 0.440 |
Why?
|
| Alcoholism | 4 | 2019 | 235 | 0.420 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2022 | 290 | 0.380 |
Why?
|
| Risk Factors | 10 | 2023 | 3108 | 0.370 |
Why?
|
| Writing | 1 | 2012 | 12 | 0.370 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 15 | 0.360 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2020 | 515 | 0.350 |
Why?
|
| Odds Ratio | 3 | 2017 | 569 | 0.350 |
Why?
|
| Sample Size | 2 | 2023 | 27 | 0.350 |
Why?
|
| Primary Health Care | 6 | 2019 | 693 | 0.350 |
Why?
|
| Back Pain | 4 | 2022 | 32 | 0.340 |
Why?
|
| Adolescent | 12 | 2020 | 3464 | 0.340 |
Why?
|
| Depressive Disorder | 3 | 2017 | 177 | 0.330 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 4 | 2015 | 35 | 0.320 |
Why?
|
| Osteoarthritis | 3 | 2014 | 15 | 0.300 |
Why?
|
| Surveys and Questionnaires | 10 | 2020 | 1204 | 0.300 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 67 | 0.280 |
Why?
|
| Cohort Studies | 12 | 2021 | 2396 | 0.270 |
Why?
|
| Aged, 80 and over | 12 | 2019 | 1887 | 0.270 |
Why?
|
| Exercise | 1 | 2013 | 513 | 0.270 |
Why?
|
| Risk Reduction Behavior | 4 | 2017 | 97 | 0.270 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 520 | 0.270 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2019 | 100 | 0.270 |
Why?
|
| Data Accuracy | 2 | 2019 | 26 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2021 | 110 | 0.260 |
Why?
|
| Mental Health Services | 2 | 2019 | 132 | 0.250 |
Why?
|
| Psychotherapy | 2 | 2017 | 55 | 0.240 |
Why?
|
| Retrospective Studies | 7 | 2022 | 2463 | 0.240 |
Why?
|
| Community Mental Health Services | 2 | 2016 | 30 | 0.230 |
Why?
|
| United States | 11 | 2022 | 3858 | 0.230 |
Why?
|
| Hypertension | 2 | 2021 | 475 | 0.230 |
Why?
|
| Motivation | 3 | 2014 | 103 | 0.210 |
Why?
|
| Substance Abuse Detection | 2 | 2014 | 16 | 0.210 |
Why?
|
| Occupations | 2 | 2014 | 15 | 0.200 |
Why?
|
| Logistic Models | 6 | 2019 | 796 | 0.200 |
Why?
|
| Outpatients | 3 | 2019 | 99 | 0.200 |
Why?
|
| Antihypertensive Agents | 2 | 2022 | 157 | 0.200 |
Why?
|
| Occupational Exposure | 2 | 2014 | 60 | 0.200 |
Why?
|
| Counseling | 2 | 2015 | 170 | 0.190 |
Why?
|
| Machine Learning | 2 | 2022 | 60 | 0.190 |
Why?
|
| Methyldopa | 1 | 2022 | 6 | 0.180 |
Why?
|
| Nifedipine | 1 | 2022 | 6 | 0.180 |
Why?
|
| International Classification of Diseases | 1 | 2022 | 84 | 0.180 |
Why?
|
| Patient Acuity | 1 | 2022 | 9 | 0.180 |
Why?
|
| Decision Making | 2 | 2014 | 164 | 0.180 |
Why?
|
| Patient Care | 1 | 2022 | 31 | 0.180 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 410 | 0.170 |
Why?
|
| Informed Consent | 1 | 2021 | 18 | 0.170 |
Why?
|
| Disability Evaluation | 2 | 2013 | 38 | 0.170 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2021 | 45 | 0.170 |
Why?
|
| Health Services | 1 | 2022 | 100 | 0.170 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 160 | 0.170 |
Why?
|
| Self Report | 6 | 2019 | 248 | 0.160 |
Why?
|
| Pregnancy | 3 | 2022 | 1555 | 0.160 |
Why?
|
| Medicaid | 1 | 2022 | 189 | 0.160 |
Why?
|
| HIV Infections | 2 | 2017 | 708 | 0.160 |
Why?
|
| Depressive Disorder, Major | 1 | 2021 | 95 | 0.160 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2021 | 51 | 0.160 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 80 | 0.160 |
Why?
|
| Alcohol Drinking | 2 | 2020 | 298 | 0.160 |
Why?
|
| Pain | 3 | 2017 | 65 | 0.160 |
Why?
|
| Eligibility Determination | 1 | 2020 | 11 | 0.160 |
Why?
|
| Washington | 5 | 2020 | 376 | 0.150 |
Why?
|
| Models, Psychological | 1 | 2019 | 21 | 0.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2020 | 23 | 0.150 |
Why?
|
| Sleep | 3 | 2014 | 54 | 0.150 |
Why?
|
| Infant, Newborn | 1 | 2022 | 828 | 0.150 |
Why?
|
| Veterans | 2 | 2017 | 143 | 0.140 |
Why?
|
| Infant | 1 | 2022 | 1212 | 0.140 |
Why?
|
| Time Factors | 6 | 2016 | 989 | 0.130 |
Why?
|
| Models, Theoretical | 2 | 2014 | 66 | 0.130 |
Why?
|
| Prescription Drug Misuse | 1 | 2017 | 8 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2016 | 261 | 0.130 |
Why?
|
| Biometry | 1 | 2017 | 13 | 0.130 |
Why?
|
| Minority Groups | 1 | 2017 | 99 | 0.130 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 1058 | 0.120 |
Why?
|
| Fibromyalgia | 1 | 2016 | 4 | 0.120 |
Why?
|
| Accidents, Traffic | 1 | 2016 | 15 | 0.120 |
Why?
|
| Vehicle Emissions | 2 | 2014 | 20 | 0.120 |
Why?
|
| Community-Institutional Relations | 1 | 2016 | 42 | 0.120 |
Why?
|
| European Continental Ancestry Group | 1 | 2017 | 400 | 0.120 |
Why?
|
| Patient Care Planning | 1 | 2015 | 43 | 0.110 |
Why?
|
| Drug Administration Schedule | 4 | 2016 | 94 | 0.110 |
Why?
|
| Documentation | 1 | 2015 | 37 | 0.110 |
Why?
|
| Cause of Death | 1 | 2016 | 171 | 0.110 |
Why?
|
| Environmental Monitoring | 1 | 2014 | 26 | 0.110 |
Why?
|
| Life Style | 2 | 2014 | 305 | 0.110 |
Why?
|
| Sex Factors | 2 | 2014 | 560 | 0.110 |
Why?
|
| Smoking | 2 | 2014 | 373 | 0.100 |
Why?
|
| Fatigue | 1 | 2014 | 30 | 0.100 |
Why?
|
| Tobacco Use Disorder | 1 | 2014 | 32 | 0.100 |
Why?
|
| Urinalysis | 1 | 2013 | 9 | 0.100 |
Why?
|
| Mass Screening | 1 | 2019 | 670 | 0.100 |
Why?
|
| Patients | 1 | 2014 | 29 | 0.100 |
Why?
|
| Electronic Mail | 1 | 2014 | 52 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 47 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2016 | 235 | 0.100 |
Why?
|
| Arthralgia | 1 | 2013 | 2 | 0.100 |
Why?
|
| Patient Selection | 1 | 2014 | 175 | 0.090 |
Why?
|
| Risk | 3 | 2019 | 453 | 0.090 |
Why?
|
| Mortality | 1 | 2013 | 116 | 0.090 |
Why?
|
| Social Support | 1 | 2013 | 195 | 0.090 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2017 | 113 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 1 | 0.080 |
Why?
|
| Patella | 1 | 2010 | 1 | 0.080 |
Why?
|
| Knee Joint | 1 | 2010 | 2 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 11 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 325 | 0.080 |
Why?
|
| Pain Management | 3 | 2015 | 56 | 0.080 |
Why?
|
| Women's Health | 1 | 2010 | 178 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2010 | 71 | 0.070 |
Why?
|
| Urinary Incontinence | 1 | 2009 | 7 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2008 | 10 | 0.070 |
Why?
|
| Low Back Pain | 1 | 2009 | 59 | 0.070 |
Why?
|
| Drug Monitoring | 2 | 2021 | 23 | 0.070 |
Why?
|
| Prevalence | 3 | 2017 | 785 | 0.070 |
Why?
|
| Health Status | 1 | 2009 | 256 | 0.060 |
Why?
|
| Obesity | 2 | 2010 | 811 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2017 | 1186 | 0.060 |
Why?
|
| Australia | 3 | 2009 | 26 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2015 | 138 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 445 | 0.050 |
Why?
|
| Prognosis | 2 | 2017 | 568 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 677 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 311 | 0.050 |
Why?
|
| Educational Status | 2 | 2014 | 163 | 0.050 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 36 | 0.050 |
Why?
|
| Age Distribution | 2 | 2015 | 221 | 0.040 |
Why?
|
| Policy | 1 | 2022 | 19 | 0.040 |
Why?
|
| Ethics Committees, Research | 1 | 2021 | 8 | 0.040 |
Why?
|
| Citalopram | 1 | 2021 | 9 | 0.040 |
Why?
|
| Fluoxetine | 1 | 2021 | 15 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 24 | 0.040 |
Why?
|
| Community Health Centers | 1 | 2022 | 58 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 12 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2014 | 995 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 191 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 67 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 294 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 516 | 0.040 |
Why?
|
| Algorithms | 1 | 2021 | 210 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 393 | 0.040 |
Why?
|
| Incidence | 1 | 2021 | 1229 | 0.030 |
Why?
|
| Anticipation, Psychological | 1 | 2017 | 1 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 45 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2017 | 48 | 0.030 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2016 | 84 | 0.030 |
Why?
|
| Stakeholder Participation | 1 | 2016 | 20 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 129 | 0.030 |
Why?
|
| Colorado | 1 | 2016 | 171 | 0.030 |
Why?
|
| Control Groups | 1 | 2015 | 2 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 98 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 816 | 0.030 |
Why?
|
| Long-Term Care | 1 | 2015 | 18 | 0.030 |
Why?
|
| Linear Models | 1 | 2016 | 187 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2016 | 87 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2015 | 164 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2015 | 112 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 305 | 0.030 |
Why?
|
| Air Pollutants, Occupational | 1 | 2014 | 14 | 0.030 |
Why?
|
| Particulate Matter | 1 | 2014 | 36 | 0.030 |
Why?
|
| Health Surveys | 1 | 2015 | 226 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 11 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 157 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2014 | 120 | 0.030 |
Why?
|
| Attitude | 1 | 2014 | 27 | 0.030 |
Why?
|
| ROC Curve | 1 | 2013 | 68 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2014 | 207 | 0.020 |
Why?
|
| Catastrophization | 1 | 2013 | 4 | 0.020 |
Why?
|
| Fear | 1 | 2013 | 14 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2014 | 242 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2013 | 21 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 88 | 0.020 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 31 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 186 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2012 | 68 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 346 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2013 | 136 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1233 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2010 | 3 | 0.020 |
Why?
|
| Anthropometry | 1 | 2010 | 54 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 571 | 0.020 |
Why?
|
| Bone Density | 1 | 2010 | 93 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 107 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 252 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2009 | 19 | 0.020 |
Why?
|
| Parity | 1 | 2009 | 53 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2008 | 33 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 657 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 489 | 0.020 |
Why?
|
| Overweight | 1 | 2009 | 262 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2010 | 925 | 0.010 |
Why?
|
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->